SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing RRP treatment has put Precigens PAPZIMEOS in focus, with traders debating whether the entrant will threaten its sales. Some see a serious competitive risk, while others argue Precigens first-mover position and Inovios accelerated-approval and commercialization hurdles limit the near-term threat.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

Energy Transfers strong quarterly results and upbeat outlook are driving discussion, with traders focused on growing natural-gas demand from data centers and new pipeline capacity. Many see the unit price as lagging the fundamentals, while others emphasize the steady distribution and the stocks typically slow price moves.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Renewed weakness in lithium prices and futures is weighing on Albemarle, with traders also watching upcoming earnings and guidance for signs of where the downturn may bottom. The community is split between expecting further declines and waiting to buy lower, and viewing the selloff as an opportunity based on longer-term battery demand.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention as its shares slide toward reported NAV, with traders debating whether its premium is unwinding and criticizing the funds management and dilution. Anthropic exposure and a potential IPO remain hoped-for catalysts, but many traders are bearish after the weak price action.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare reimbursement could decline sharply after the first quarter of 2027 has fueled concern about pricing and CorMedixs largest revenue driver, amid a steep selloff. Traders disagree over the impact: some view DaVitas estimates as preliminary and not company revenue guidance, while others fear sustained reimbursement pressure.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys earnings and improving parks and streaming performance are supporting a bullish conversation, alongside traders watching for a technical breakout. Others remain skeptical, citing the stocks long-running stagnation and resistance near recent levels.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

A newly disclosed convertible-note financing and proposed increase in authorized shares have put dilution at the center of the discussion, with traders worried that price-linked conversions could add selling pressure and further erode confidence in management. Some holders argue the funding is needed to advance data-center projects and point to AI infrastructure demand, while others say execution and financing risks outweigh that potential.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

RIG is drawing attention around progress toward completing its Valaris merger, alongside bullish options activity and optimism about rising offshore dayrates and contract backlog. Traders see potential for a breakout or short squeeze, while others worry about merger-related dilution, debt, and a tendency for rallies to fade.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A sharp selloff and put-heavy options flow have focused attention on AEHR, with traders debating whether the decline reflects stretched valuation and fading momentum or an opportunity ahead of earnings. Bulls are looking for confirmation of the companys AI-related growth outlook and additional orders, while bears remain concerned about execution and the lack of fresh customer wins.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Targets quarterly earnings beat and higher full-year outlook, supported by improving traffic and sales, have renewed attention on its turnaround. Traders are upbeat about the operational momentum but question how durable the gains are because tariff refunds boosted reported results, and some point to slowing comparable-sales growth and a sell-the-news pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday's pre-market session. The company's market cap stands at $7.0 million.
Aligos Therapeutics (NASDAQ:ALGS) sharesread more...

Aligos Therapeutics Stock Is Trending Overnight: Here's What's Going On With ALGS Stock

Aligos Therapeutics stock rose in after-hours trading after a $25 million licensing payment and China Breakthrough Therapy designation.read more...

ALGS Stock Rallies 16% After-Hours On $25M Cash Boost From China Hepatitis B Drug Deal 

Equity

The payment gives Aligos non-dilutive funding as it advances its pipeline of treatments for liver and viral diseases.

Aligos Therapeutics Says China Pact Puts HBV Drug In Focus Amid Trial Updates

Aligos shares rise after China licensing deal for HBV drug; milestones, trial updates, and technical levels shape investor outlook.read more...

This Micro Cap Biotech Stock Is Tracking Its Biggest Intraday Gains In 11 Months – Here’s Why A China Deal Has Retail Buzzing

Aligos Therapeutics announced a licensing deal with Xiamen Amoytop Biotech to develop and commercialize its hepatitis B drug candidate in Greater China.

Aligos Therapeutics Earnings Report: Q4 Overview

A Peek at Aligos Therapeutics's Future Earnings

Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5% - Time to Sell?

Aligos Therapeutics (NASDAQ:ALGS) Trading Down 4.5% - Here's What Happened...

Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 737.7% in Aligos Therapeutics (ALGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia

SNY wins FDA approval for Wayrilz, the first BTK inhibitor for immune thrombocytopenia, with broader rare disease studies underway.

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.

Aligos Therapeutics Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Under the licensing deal signed earlier this year, Aligos granted Xiamen Amoytop Biotech exclusive rights to develop and sell its experimental hepatitis B treatment drug, pevifoscorvir sodium, in Greater China.</li><li>Under the deal, Aligos is eligible for up to $420 million in milestone payments tied to clinical, regulatory, and sales achievements.</li><li>Aligos Therapeutics had $54.9 million in cash, cash equivalents and short-term investments as of March 31, 2026.</li></ul> Shares of Aligos Therapeutics (ALGS) rose 21% in after-hours trading on Monday after the company announced it had received a $25-million upfront payment from its Chinese licensing partner.The payment gives Aligos non-dilutive funding as it advances its pipeline of treatments for liver and viral diseases. Aligos Therapeutics had only $54.9 million in cash, cash equivalents, and short-term investments as of March 31, 2026.<h2 class="st-heading-2">The Licensing Deal</h2>Under the licensing deal signed earlier this year, Aligos granted Xiamen Amoytop Biotech exclusive rights to develop and sell its experimental hepatitis B treatment, pevifoscorvir sodium, in Greater China. Aligos keeps full rights to the drug in the United States, Europe, Japan, South Korea, and all other markets.Under the deal, Aligos is eligible for up to $420 million in milestone payments tied to clinical, regulatory and sales achievements. It will also earn tiered royalties in the high single digits on net sales in the licensed region.The treatment has already received Breakthrough Therapy Designation from Chinese regulators, which can speed up the approval process. A joint steering committee between the two companies is now overseeing the program. As part of the broader collaboration, the partners also plan to start clinical testing in China of another Aligos drug candidate in the third quarter of this year.<h2 class="st-heading-2">How Did ALGS Retail Traders React?</h2>On Stocktwits, retail sentiment around ALGS stock jumped from ‘neutral’ to ‘bullish’ over the past 24 hours, while message volume stayed at ‘high’ levels.A Stocktwits user opined that the stock is highly undervalued.<stembedurl>https://www.stocktwits.com/saitek88/message/658388690</stembedurl>“Cash-in now, but the real read is whether this deal de-risks the story and adds validation for the asset. Market will watch follow-through on the platform, not just the headline,” another user wrote.<stembedurl>https://www.stocktwits.com/SmartCapitall/message/658384603</stembedurl><a href="https://stocktwits.com/symbol/ALGS">ALGS stock</a> has fallen by about 37% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/rivn-stock-drops-after-hours-on-potential-1.5-billion-offering/cZm1A9rR7lC">RIVN Stock Drops After-Hours On Potential $1.5B Offering Despite Upbeat Q2 Guidance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Interactive Strength Inc. rose on Friday (Representative image: Getty Images)

Vanguard Total Stock Market ETF

Vanguard Extended Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$ALGS how we doing over here? Doing standard $ALGS things? Back to the $3S because…..why not. There’s this dark corner of the market where a bunch of stocks reside.  These stocks have the “nobody cares”  label on them.  The shares serve one purpose. Sell them to keep salaries paid. They are not intended to appreciate.  Once you come to grips with this, it all makes sense. Heard from the CEO in months?   Maybe his music career is starting to take off and he’s distracted?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALGS Aligos Therapeutics Inc

Fundamentals

Latest ALGS News